Notice: This company has been marked as potentially delisted and may not be actively trading. EQRx (EQRX) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period Absci Corporation Leverages AI For Rapid Drug Discovery And Promising PartnershipsJuly 28, 2024 | seekingalpha.com599 Cancer Monoclonal Antibody Collaboration and Licensing Deals Report and Directory 2016-2024May 7, 2024 | finance.yahoo.comRevolution Medicines, Inc. (NASDAQ:RVMD) Q4 2023 Earnings Call TranscriptFebruary 28, 2024 | finance.yahoo.comRevolution Medicines, Inc.: Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate ProgressFebruary 27, 2024 | finanznachrichten.deRevolution Medicines Inc (RVMD) Reports Earnings: R&D Investments Surge Amidst Clinical ProgressFebruary 26, 2024 | uk.finance.yahoo.comAbCellera Biologics (ABCL) Q4 2023 Earnings Call TranscriptFebruary 21, 2024 | msn.comGubra AS GUBRAFebruary 1, 2024 | morningstar.comSoftBank adds stakes in Neumora, Globalstar in Q3; stake in WeWork slashedNovember 14, 2023 | msn.comRevolution Medicines, Inc.: Revolution Medicines and EQRx Stockholders Approve EQRx AcquisitionNovember 9, 2023 | finanznachrichten.deRevolution Medicines, Inc.: Revolution Medicines Completes Acquisition of EQRxNovember 9, 2023 | finanznachrichten.deTrading was temporarily halted for "EQRX" at 07:11 PM with a stated reason of "News pending."November 9, 2023 | marketbeat.comRevolution Medicines and EQRx stockholders approves acquisitionNovember 8, 2023 | msn.comRevolution Medicines, Inc.: Revolution Medicines Reports Third Quarter 2023 Financial Results and Update on Corporate ProgressNovember 7, 2023 | finanznachrichten.deWe're Hopeful That EQRx (NASDAQ:EQRX) Will Use Its Cash WiselyNovember 2, 2023 | finance.yahoo.comCalling All EQRx, Inc. (EQRX) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your LossesOctober 20, 2023 | barrons.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMNB, NEWR, EQRX, SCUOctober 8, 2023 | benzinga.comEQRX Shareholder Investigation: Robbins LLP Reminds Shareholders it is Investigating EQRx, Inc. on behalf of ShareholdersSeptember 27, 2023 | benzinga.comApplied BioMath, LLC Hosts 6th Annual Quantitative Systems Pharmacology SummitSeptember 26, 2023 | finance.yahoo.comProfund Advisors LLC Acquires New Position in EQRx, Inc. (NASDAQ:EQRX)Profund Advisors LLC acquired a new stake in shares of EQRx, Inc. (NASDAQ:EQRX - Free Report) in the first quarter, according to the company in its most recent filing with the SEC. The firm acquired 204,268 shares of the company's stock, valued at approximately $396,000. A number of other institutiSeptember 5, 2023 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Has $845,000 Stock Holdings in EQRx, Inc. (NASDAQ:EQRX)Connor Clark & Lunn Investment Management Ltd. increased its holdings in EQRx, Inc. (NASDAQ:EQRX - Free Report) by 32.6% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 435,404 shares of the company's stockAugust 24, 2023 | marketbeat.comSG Americas Securities LLC Has $134,000 Stake in EQRx, Inc. (NASDAQ:EQRX)SG Americas Securities LLC decreased its stake in EQRx, Inc. (NASDAQ:EQRX - Free Report) by 49.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 68,859 shares of the company's stock afteAugust 14, 2023 | marketbeat.comEQRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of EQRx, Inc. - EQRXAugust 3, 2023 | businesswire.comRevolution Medicines will buy EQRx in an all-stock transactionAugust 1, 2023 | msn.comEQRx sells to another Alexis Borisy biotech after multiple pivotsAugust 1, 2023 | bizjournals.comRevolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional CapitalAugust 1, 2023 | finance.yahoo.comEQRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of EQRx, Inc. Is Fair to ShareholdersAugust 1, 2023 | businesswire.comTrading was temporarily halted for "EQRX" at 06:08 AM with a stated reason of "News pending."August 1, 2023 | marketbeat.comShort Interest in EQRx, Inc. (NASDAQ:EQRX) Rises By 5.4%EQRx, Inc. (NASDAQ:EQRX - Get Free Report) was the target of a significant growth in short interest in June. As of June 30th, there was short interest totalling 19,010,000 shares, a growth of 5.4% from the June 15th total of 18,030,000 shares. Based on an average daily trading volume, of 1,950,000 shares, the days-to-cover ratio is presently 9.7 days. Currently, 7.4% of the company's stock are sold short.July 21, 2023 | marketbeat.comEQRx, Inc. (NASDAQ:EQRX) has caught the attention of institutional investors who hold a sizeable 47% stakeJune 29, 2023 | finance.yahoo.comUBS Group AG Grows Stake in EQRx, Inc. (NASDAQ:EQRX)UBS Group AG grew its holdings in EQRx, Inc. (NASDAQ:EQRX - Get Rating) by 888.2% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 812,247 shares of the company's stock after acquiring an additional 730,056 shares during the quarter. UBS GroJune 6, 2023 | marketbeat.comCornercap Investment Counsel Inc. Buys New Stake in EQRx, Inc. (NASDAQ:EQRX)Cornercap Investment Counsel Inc. purchased a new position in shares of EQRx, Inc. (NASDAQ:EQRX - Get Rating) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 105,598 shares of the company's stock, vaJune 2, 2023 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Takes $808,000 Position in EQRx, Inc. (NASDAQ:EQRX)Connor Clark & Lunn Investment Management Ltd. purchased a new stake in EQRx, Inc. (NASDAQ:EQRX - Get Rating) during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 328,482 shares of the company's stock, valued at approximately $808,000. Connor Clark & LunnJune 1, 2023 | marketbeat.comCStone Breaks Up With Drugs Partner As U.S. Rollout StallsMay 19, 2023 | seekingalpha.comOppenheimer & Co. Inc. Has $37,000 Stock Position in EQRx, Inc. (NASDAQ:EQRX)Oppenheimer & Co. Inc. lowered its stake in EQRx, Inc. (NASDAQ:EQRX - Get Rating) by 84.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 15,000 shares of the company's stock after selling 83,000 shares during the quarter. OppenheMay 17, 2023 | marketbeat.comThe World Has Its Way With EQRxMay 10, 2023 | msn.comQ1 2023 EQRx Inc Earnings CallMay 9, 2023 | finance.yahoo.comEQRx Announces Massive Strategic Reset, Slashes Pipeline & WorkforceMay 9, 2023 | markets.businessinsider.comEQRx, Inc. (EQRX) Q1 2023 Earnings Call TranscriptMay 8, 2023 | seekingalpha.comEQRx GAAP EPS of -$0.17 misses by $0.03May 8, 2023 | msn.comEQRx Resets to Focus on Clinically Differentiated Medicines, Leveraging $1.3 Billion Cash Position; Reports First Quarter 2023 Financial ResultsMay 8, 2023 | finance.yahoo.comEQRx Resets to Focus on Clinically Differentiated Medicines, Leveraging $1.3 Billion Cash Position; Reports First Quarter 2023 Financial ResultsMay 8, 2023 | finance.yahoo.comHandelsbanken Fonder AB Purchases New Position in EQRx, Inc. (NASDAQ:EQRX)Handelsbanken Fonder AB purchased a new stake in EQRx, Inc. (NASDAQ:EQRX - Get Rating) during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 133,100 shares of the company's stock, valued at approximately $327,000. A number of other hedge funds have also modMay 8, 2023 | marketbeat.comEarnings Outlook For EQRxMay 5, 2023 | msn.comEQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023April 27, 2023 | finance.yahoo.comEQRx, Inc. (EQRX) Shareholder Investigation: Robbins LLP is Investigating EQRX, Inc. on behalf of ShareholdersApril 21, 2023 | technews.tmcnet.comVBI Vaccines (VBIV) Down 53% on Initiating Restructuring PlansApril 5, 2023 | msn.comEQRx Chief Financial Officer Jami Rubin Resigns >EQRXMarch 13, 2023 | marketwatch.comAlphabet Inc. Takes $235.39 Million Position in EQRx, Inc. (NASDAQ:EQRX)Alphabet Inc. purchased a new position in EQRx, Inc. (NASDAQ:EQRX - Get Rating) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 47,552,687 shares of the company's stock, valued at approximately $235,386,000. EQRx coMarch 13, 2023 | marketbeat.comCompany founded to make 'radically' cheap drugs lays off 66February 24, 2023 | bizjournals.comEQRx Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate ProgressFebruary 23, 2023 | finance.yahoo.com Get EQRx News Delivered to You Automatically Sign up to receive the latest news and ratings for EQRX and its competitors with MarketBeat's FREE daily newsletter. Email Address The death of Nvidia? (Ad)Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming. So go here now to read my new report The Big AI Die-Up… while you still can. EQRX Media Mentions By Week EQRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EQRX News Sentiment▼0.000.66▲Average Medical News Sentiment EQRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EQRX Articles This Week▼00▲EQRX Articles Average Week Get EQRx News Delivered to You Automatically Sign up to receive the latest news and ratings for EQRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LIAN News Today PHXM News Today KLDO News Today DRTSW News Today BCTXW News Today EFTRW News Today FBIOP News Today GOVXW News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EQRX) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredWall St. Icon: Looming Financial Tsunami will Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event will hit the American...InvestorPlace | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredIt’s over.We found a tiny company which provides the backbone for the entire $15.7 trillion AI industry... It's used ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EQRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share EQRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free eqrx Stock Alerts